N
MGNX icon

Nuveen’s MacroGenics MGNX Stock Holding History

Nuveen’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-198,470
Closed -$252K – 3347
2025
Q1 		$252K Hold
198,470
– – ﹤0.01% 3072
2024
Q4 		$645K Hold
198,470
– – ﹤0.01% 2889
2024
Q3 		$653K Hold
198,470
– – ﹤0.01% 2922
2024
Q2 		$843K Sell
198,470
-351,170
-64% -$3.42M ﹤0.01% 2803
2024
Q1 		$8.09M Sell
549,640
-57,571
-9% -$870K ﹤0.01% 1735
2023
Q4 		$5.84M Sell
607,211
-327,770
-35% -$2.27M ﹤0.01% 1897
2023
Q3 		$4.36M Sell
934,981
-1,476
-0.2% -$7.35K ﹤0.01% 1933
2023
Q2 		$5.01M Buy
936,457
+252,840
+37% +$1.56M ﹤0.01% 1911
2023
Q1 		$4.9M Buy
683,617
+166,058
+32% +$1M ﹤0.01% 1901
2022
Q4 		$3.47M Buy
517,559
+20,120
+4% +$110K ﹤0.01% 2119
2022
Q3 		$1.72M Buy
497,439
+170,615
+52% +$653K ﹤0.01% 2473
2022
Q2 		$965K Buy
326,824
+23,070
+8% +$121K ﹤0.01% 2792
2022
Q1 		$2.66M Sell
303,754
-38,731
-11% -$428K ﹤0.01% 2377
2021
Q4 		$5.5M Sell
342,485
-9,275
-3% -$175K ﹤0.01% 2063
2021
Q3 		$7.37M Sell
351,760
-24,716
-7% -$595K ﹤0.01% 1996
2021
Q2 		$10.1M Sell
376,476
-27,027
-7% -$791K ﹤0.01% 1855
2021
Q1 		$12.9M Sell
403,503
-469,718
-54% -$11.4M ﹤0.01% 1636
2020
Q4 		$20M Sell
873,221
-18,746
-2% -$432K 0.01% 1269
2020
Q3 		$6.78M Buy
891,967
+127,172
+17% +$3.47M ﹤0.01% 1755
2020
Q2 		$5.81M Sell
764,795
-126,760
-14% -$2.2M ﹤0.01% 1816
2020
Q1 		$5.19M Buy
891,555
+184,660
+26% +$1.68M ﹤0.01% 1696
2019
Q4 		$7.69M Buy
706,895
+3,007
+0.4% +$29.8K ﹤0.01% 1746
2019
Q3 		$8.98M Sell
703,888
-95,235
-12% -$1.37M ﹤0.01% 1644
2019
Q2 		$13.6M Buy
+799,123
New +$13.7M 0.01% 1412

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen's MGNX Position: Q2 2025 in Review

Nuveen sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 198,470 shares — an estimated $252K sold.

Nuveen first reported a position in MGNX in Q2 2019 and held it in 24 quarters. The position peaked at $20M in Q4 2020. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Nuveen reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 198,470 MacroGenics shares in Q2 2025, an estimated $252K.
  • Nuveen first reported a position in MacroGenics in Q2 2019 and held it in 24 quarters.
  • Nuveen's MacroGenics position peaked at $20M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.